Astellas at AAPS 2026 PharmSci 360
Oct 25–28, 2026 New Orleans, LA ~4k attendees Website
Astellas brings 3 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its work centres on drug stability, from predicting antibody stability to light-driven aggregation in an antibody-drug conjugate. Projects also use lipid-based formulations to make a poorly soluble middle-sized molecule work as an oral drug.
| Organization | AAPS 2026 PharmSci 360 Attendance |
|---|---|
Astellas Tokyo, Japan | |
Japanese pharmaceutical company with marketed medicines in oncology, urology, immunology and other areas. | Poster Tue Oct 27 2:30pm–3:30pm Peak-Level Kinetic Modeling and Mass Balance-Based Reconstruction for Improved Antibody Stability Prediction Poster Wed Oct 28 9:30am–10:30am Oral Enablement of a Poorly Soluble Middle Molecule Using Lipid-Based Formulations: Incremental Stability Gains from Antioxidants and Silica Adsorption Solidification Poster Wed Oct 28 10:30am–11:30am Oxidation-Independent Pathway of Photoinduced Aggregation in an Antibody-Drug Conjugate |
Instantly find 20 buyers from Astellas
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction